Concepedia

Ashley Sumrall

AS

28

Publications

2.4K

Citations

21

H-Index

2007

Active since

Affiliations

Levine Cancer Institute(Current)

University of California, San Francisco

Dana-Farber Cancer Institute

Emory University

Southeast Radiation Oncology Group

Ashley Sumrall is an author at Levine Cancer Institute specializing in medicine, neuro-oncology, and glioma.

ORCID

Top concepts

Publications per year

2007–2024

28

Publications

28

Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated <i>MGMT</i> promoter

Michael Lim, Michael Weller, Ahmed Idbaïh et al. · Neuro-Oncology · 2022 · 450 citations · Full text

Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated <i>MGMT</i> promoter: An international randomized phase III trial

Antonio Omuro, Alba A. Brandes, Ahmed Idbaïh et al. · Neuro-Oncology · 2022 · 435 citations · Full text

Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series

Emil Lou, Ashley Sumrall, Scott Turner et al. · Journal of Neuro-Oncology · 2012 · 193 citations · Full text

,

Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201

S. Andrew, Rohinton S. Tarapore, Matthew D. Hall et al. · Journal of Neuro-Oncology · 2019 · 187 citations

, , +8

Clinical Practice Experience With NovoTTF-100A™ System for Glioblastoma: The Patient Registry Dataset (PRiDe)

Maciej M. Mrugała, Herbert H. Engelhard, David Tran et al. · Seminars in Oncology · 2014 · 143 citations · Full text

, , +21

Rows per page

1–5 of 28